$0.02
0[0.00%]
Last update: 9:32AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 5.869K | Mkt Cap23.359M |
| Day Range- - - | 52 Wk Range0.000 - 0.065 |
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bonus BioGroup Stock (OTC:BBIXF), Key Statistics
Bonus BioGroup Stock (OTC: BBIXF) analysis, key statistics.
Valuation Measures
Enterprise Value
41.6M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
2.06
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-78.76%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.01
Tangible Book value per share
0.01
Total Liabilities (Quarterly)
15.9M
Total Assets
59M
Total Liabilities
15.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -